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ABSTRACT 
The healing of chronic wounds requires intensive medical intervention at huge healthcare 
costs. Dressing materials should consider the multifactorial nature of these wounds comprising 
deleterious proteolytic and oxidative enzymes, and high bacterial load. In this work, 
multifunctional hydrogels for chronic wound application were produced by enzymatic 
crosslinking of thiolated chitosan and gallic acid. The hydrogels combine several beneficial to 
wound healing properties, controlling the matrix metalloproteinases (MMPs) and 
myeloperoxidase (MPO) activities, oxidative stress and bacterial contamination. In vitro studies 
revealed above 90 % antioxidant activity, and MPO and collagenase inhibition by up to 98 and 
23 %, respectively. Ex vivo studies with venous leg ulcer exudates confirmed the inhibitory 
capacity of the dressings against MPO and MMPs. Additionally, the hydrogels reduced the 
population of the most frequently encountered in non-healing wounds bacterial strains. The 
stable at physiological conditions and resistant to lysozyme degradation hydrogels showed high 
biocompatibility with human skin fibroblasts.  
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INTRODUCTION 
Wounds that do not show signs of healing within three to six weeks are described as chronic 
wounds and require resource-consuming and dedicated nursing care with treatment regimens that 
are expensive and/or ineffective. Furthermore, the management of these clinically compromised 
wounds represents a significant cost for the national health systems and has become a major 
therapeutic challenge due to the ageing population and increasing incidence of conditions that 
impede wound healing, such as diabetes, obesity and vascular disorders,1 further worsening the 
morbidity.2 Despite not sharing origin or cause, and being clinically and molecularly 
heterogeneous, the chronic wounds exhibit the following common features - bacterial 
contamination and high concentration of reactive oxidative species (ROS), myeloperoxidase 
(MPO) and matrix metalloproteinases (MMPs).3 In chronic wounds, however, the imbalance 
between the elevated levels of MMPs and the tissue inhibitors of matrix metalloproteinases 
(TIMPs) causes an excessive degradation of the extracellular matrix (ECM) and growth factors.4 
Furthermore, the activation of MMPs and the degradation of TIMPs and growth factors are 
triggered by the MPO. In addition, several bacterial species, e.g. Staphylococcus aureus (S. 
aureus), Pseudomonas aeruginosa (P. aeruginosa) and Escherichia coli (E. coli) colonize most 
chronic wounds. On the other hand, it is known that compounds able to chelate the Zn2+ from the 
active centre of the enzyme would inactivate it.5 This is the principle of action of the most potent 
MMPs inhibitors – the hydroxamates.6 Similarly, the thiols are reported as inhibitors of MMPs.7 
Incorporating thiols in the structure of the hydrogels is the initial hypothesis for the MMPs 
controlling activity of the hydrogels. 
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Because of the multifactorial nature of the chronic wounds, any single therapeutic intervention 
is unlikely to have satisfactory healing effect. An efficient therapeutic approach for chronic 
wound healing should necessarily: i) control the infection-related proteolytic and oxidative 
enzymatic activities in the wound site, ii) provide microorganisms-free environment, and iii) 
maintain the tissue moisture while absorbing the excessive exudates.8 Therefore, chronic wound 
dressings should combine both antimicrobial and enzyme inhibitory functions coupled to high 
hydrophilicity. However, the dressing materials that dominate the market9 are mostly 
biologically inert hydrogels, whose only functionality is to retain the exudate and maintain the 
wound moist.10 In the most advanced designs, the same hydrogels are loaded with antimicrobial 
agents, e.g. silver,11 to prevent or heal microbial infection. Towards the development of therapies 
to treat chronic wounds comprising the aforementioned characteristics, hydrogels with different 
functionalities have been suggested.12 Chitosan-based hydrogels alone or in combination with 
other biopolymers have been widely applied in tissue engineering,13 regenerative medicine,14 
drug delivery,15 and wound healing.16 Chitosan, a copolymer of glucosamine and N-acetyl-D-
glucosamine derived by deacetylation of chitin from fungal or crustacean origin, is a valuable for 
medical applications polysaccharide due to its biocompatibility, biodegradability, lack of 
cytotoxicity and intrinsic antimicrobial activity.17 The major drawback of chitosan-based 
hydrogels is their poor biostability and mechanical strength that must be enhanced by additional 
chemical, e.g. glutaraldehyde18 or carbodiimide19 crosslinking which often produces toxic 
residues unsuitable for medical applications.  
Alternatively, our group has developed covalently crosslinked gels obtained via enzyme-
catalyzed reactions applying mild conditions and avoiding the use of harsh chemicals.8,20 
Modifying the polysaccharide structure can further refine the mechanical and functional 
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properties of chitosan-based hydrogels. Combining thiolated chitosan (TCS) with polyphenols 
would increase its mechanical stability,21 antioxidant and antibacterial activity, and the inhibition 
efficiency against MPO and MMPs. Upon treatment with oxidative enzymes, such as tyrosinase, 
peroxidase and laccase, polyphenols undergo oxidative transformation into quinones. These 
highly reactive species can interact with nucleophilic groups from chitosan, which will 
additionally stabilize the hydrogel structure via inter- and intra-molecular coupling. Oxidases 
have been largely used in our group to produce biopolymer-based hydrogels,8,20 antimicrobial 
filters,22 antifouling urinary catheters,23 and functionalized protein fibers.24,25 In particular, 
laccase has been recognized as a ‘green enzyme’, since it uses O2 from the air and produces H2O 
as the only by-product.26 The phenolic compound we selected for the current study was the 
naturally occurring gallic acid (GA) owing to its strong antioxidant activity,27 demonstrated 
MPO inhibition and lack of toxicity.28 
The aim of this work is to develop hydrogel-based dressings in a one-step laccase-catalyzed 
crosslinking reaction for chronic wounds with tunable physicomechanical and functional 
properties, which rely on intrinsic antimicrobial and wound repair properties as matrix material 
(TCS) further upgraded with bioactive molecules (GA) that couple high reactivity with the 
ability to address specific targets in the biochemical environment of chronic wounds in order to 
stimulate the healing process. Herein, we suggest that the thiolation of chitosan would have a 
synergistic effect improving the mechanical properties of chitosan-based hydrogels by disulfide 
formation, and enhancing the inhibitory capability of chitosan against MMPs by chelation of the 
Zn2+ from their active center. 
The resulting hydrogels are expected to: i) absorb the wound exudate and keep the moist 
environment of the wound, ii) provide a wound environment with controlled ROS, MMPs and 
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MPO activities, and iii) reduce the bacterial contamination in the wound bed. The efficiency of 
the developed dressing materials will be evaluated in vitro against major factors governing the 
chronicity in wounds. The morphology, swelling properties and rheological characteristics of the 
hydrogels together with their stability at physiological conditions will be further examined. 
Finally, the inhibitory capacity of the hydrogels towards deleterious chronic wound enzymes will 
be assessed ex vivo in the complex environment of a wound exudate collected from a venous leg 
ulcer.  
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MATERIALS AND METHODS 
Reagents and enzymes 
Medical grade chitosan from fungi (15 kDa, degree of deacetylation 87 %) was obtained from 
KitoZymes (Belgium). Traut’s reagent (2-iminothiolane hydrochloride), L-cysteine, sodium 
phosphate mono- and dibasic, gallic acid, acetic acid, sodium chloride, zinc dichloride, 
ammonium chloride, ammonium hydroxide, hydrochloric acid, Elman’s reagent (5,5’-dithiobis-
(2-nitrobenzoic acid)), sodium hydroxide, hydrogen peroxide, sodium acetate, sodium carbonate, 
phosphate buffered saline (PBS), ethylenediaminetetraacetic acid disodium salt (EDTA), 1,1-
diphenyl-2-picrylhydrazyl, Bradford reagent (Coomasie Brilliant Blue G), Eriochrome Black T, 
Folin & Ciocalteu’s phenol reagent, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS) and guaiacol were provided from Sigma-Aldrich (Spain). 
Collagenase from Clostridium hystolyticum type I (EC 3.4.24.3, 244.9 U/mg solid: 1 U 
hydrolyzes 1.0 µmol of furylacryloyl-Leu-Gly-Pro-Ala per min at 25 ºC) and lysozyme from 
chicken egg white (EC 3.2.1.17, 100000 U/mg where 1 U corresponds to the amount of enzyme 
which decreases the absorbance at 450 nm by 0.001 per min at pH 7.0 and 25 ºC of Micrococcus 
luteus, ATCC 4698, as a substrate) were purchased from Sigma-Aldrich. Laccase (EC 1.10.3.2, 
Denilite II Base from Myceliophthora thermophila expressed in Aspergillus oryzae, 8.6 U/mg 
where 1 U corresponds to the amount of enzyme which catalyzes the oxidation of 1 µmol ABTS 
per min at pH 5.5 and 25 ºC) was provided by Novozymes (Denmark). Myeloperoxidase (MPO) 
from human leukocytes (EC 1.11.2.2, 1550 U/mg solid: 1 U produces an increase of 1.0 
absorbance unit per min. at 470 nm at pH 7.0 and 25 ºC, using guaiacol as a substrate) was 
purchased from Planta Natural Products (Austria). EnzChek Gelatinase/Collagenase Assay Kit 
was provided from Molecular Probes (USA). 
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Preparation of the hydrogels 
The thiolation of chitosan was carried out in a one-step coupling reaction between Traut’s 
reagent and the primary amino groups of chitosan to obtain chitosan-thiobutylamidine.29 The 
coupling reaction allows the functionalization of the biopolymer with free thiol groups, while the 
established amidine linkages increase its cationic character and potentially its antimicrobial 
activity.30 Briefly, chitosan was dissolved in CH3COOH at 1 % w/v final concentration. 
Thereafter, the pH was adjusted to ~6.5 with 5 M NaOH and different amounts of Traut’s 
reagent, based on our previous work,30 were added to prepare chitosan batches with variable 
degree of thiolation (Table 1).  The mixtures were stirred at room temperature under dark for 24 
h. Afterwards, the preparations were dialyzed once against 5 mM HCl with 1 % NaCl, twice 
against 1 mM HCl with 1 % NaCl and once more extensively against 1 mM HCl prior 
lyophilization and storage at 4 ºC under nitrogen atmosphere until further use. 
Table 1. Thiolated chitosan samples (TCS) 
Sample code 
Reaction ratio 
chitosan: Traut’s 
µmols free -SH per 
g polymer 
TCS 1-10 10:1 389 ± 19.2 
TCS 1-5 5:1 469.4 ± 26.1 
TCS 2-5 5:2 523.4 ± 24.5 
The amount of free thiol groups, immobilized on chitosan was assessed using Ellman’s 
reagent.31 Briefly, 1 mg of the lyophilized material was immersed for 20 min in 500 µL 0.5 M 
phosphate buffer, pH 8. Afterwards 500 µL of Ellman’s reagent (3 mg in 10 mL of the same 
aforementioned buffer) were added and the samples were left for 3 h in dark conditions. The 
mixtures were centrifuged during 5 min at 5000 rpm. Then the supernatant was transferred to a 
microplate reader Infinite M200, Tecan (Austria) and its absorbance was monitored at 450 nm. 
L-cysteine standards were used for building a calibration curve and non-thiolated chitosan was 
used as a control sample. 
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The hydrogels were obtained by laccase-catalyzed crosslinking of TCS and GA at pH 5.5 and 
50 ºC. According to the provider’s specification, at this temperature the enzyme reaches 80 % of 
its maximum activity, achieved at 65 – 70 ºC. Briefly, solutions comprising 1.6 mL TCS (7 % 
w/v), 0.2 mL laccase (2.7 U/mL) and different volumes of 75 mM GA (200, 134 and 67 μL) 
were prepared. The volume of each mixture was adjusted to 2 mL by adding acetate buffer (0.1 
M, pH 5.5) and the mixtures were transferred to a 6-well plate by a syringe equipped with a 21G 
needle in order to maintain all gel preparation conditions equal. To evaluate the influence of: i) 
the time of incubation of the hydrogels with laccase (2, 4 and 6 h), ii) the degree of thiolation of 
chitosan (TCS1-10, TCS1-5, TCS2-5), and iii) the amount of 75 mM GA, different batches of 
hydrogels (Table 2) were prepared. The aforementioned solutions of TCS and GA without 
laccase were freeze-dried and used as controls. 
Table 2. Samples of thiolated chitosan/gallic acid hydrogels  
Sample 
code 
Thiolated 
chitosan 
Gallic acid  
(mM) 
Time of incubation     
with laccase (h) 
2.5TCS1-10 TCS1-10 2.5 2, 4, 6 
5TCS1-10 TCS1-10 5 2, 4, 6 
7.5TCS1-10 TCS1-10 7.5 2, 4, 6 
2.5TCS1-5 TCS1-5 2.5 2, 4, 6 
5TCS1-5 TCS1-5 5 2, 4, 6 
7.5TCS1-5 TCS1-5 7.5 2, 4, 6 
2.5TCS2-5 TCS2-5 2.5 2, 4, 6 
5TCS2-5 TCS2-5 5 2, 4, 6 
7.5TCS2-5 TCS2-5 7.5 2, 4, 6 
 
To determine their phenolic content, the lyophilized hydrogels (1.4 mg each) were immersed 
in 70 μL 0.2 N Folin-Ciocalteu reagent, 1.2 mL of Milli-Q water and 120 µL 20 % w/v Na2CO3. 
The mixture was placed in dark conditions at room temperature for 1 h. Afterwards 300 μL of 
each solution were transferred to a 96-well microplate and the absorbance was recorded at 765 
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nm. The results were expressed as percentage of free phenol groups remaining after the 
incubation with laccase.  
The polyphenols release was assessed as follows: the lyophilized hydrogel samples (2 mg 
each) were immersed in 500 μL PBS buffer (pH 7.4) for 24 h at 37 ˚C. Then, the phenol content 
of 400 μL supernatant was assessed as described above. The results were expressed as the 
percentage release of polyphenols from the initial concentration of GA, used for the preparation 
of the hydrogels. 
 
Rheological, structural and morphological characterization of the hydrogels  
Rheological characterization of the hydrogels was performed with an ARG2 rheometer (TA 
instruments, UK), equipped with electrical heated plates. The samples were analyzed in parallel 
plate geometry (40 mm). The rheometer was set in the oscillatory mode (2 Hz frequency) with 
controlled strain (2 %) used to monitor the crosslinking process. The blends were placed onto the 
Peltier plate at 25 ºC and the measurements started after thermal equilibration to 50 ºC. The 
gelation point was determined by using G’ and G’’ crossover criterion. 
The structural features of the hydrogels after lyophilization were examined with FTIR over 
4000-650 cm-1 range with Perkin-Elmer Spectrum 100 (Perkin-Elmer, Massachusetts, USA). 
Each sample was subjected to 64 scans. In order to elucidate the mechanism of crosslinking, the 
FTIR-spectra of a low molecular weight model compound of TCS, containing both amino and 
thiol groups namely L-cysteine, was studied. 
The lyophilized hydrogels’ morphology was studied by scanning electron microscopy (JSM 
5610, JEOL Ltd. Japan). Cross-sections of the hydrogel samples were gold-sputtered under 
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vacuum and micrographs were recorded at 250x magnification. The pore size of the hydrogels 
was quantified using ImageJ 1.5 software.  
In order to determine their swelling equilibrium, the hydrogels were swollen/immersed in PBS, 
pH 7.4 at 37 ºC up to 24 hours. The samples were periodically removed from the media and 
weighted until no further change in their weight was determined. Within 6 hours the swelling 
equilibrium of all samples was reached. The stability of the hydrogels upon enzymatic 
degradation in physiological liquids was assessed in presence of lysozyme (100000 U/mL).8 The 
medium was refreshed and the hydrogels weighted once per day during six days. The results 
were compared to those obtained following the same procedure but omitting the enzyme. All 
experiments were performed in five replicates and the average weight loss was calculated, 
according to the following equation (1): 
 Weight loss (%) = 100(Ws - Wlys)/Ws  (1) 
where Ws is the weight of the wet hydrogel at swelling equilibrium in PBS and Wlys is the weight 
of the sample after lysozyme degradation. 
The swelling properties of the hydrogels were determined by comparing the weight of the dry 
lyophilized samples and the weight of the swollen hydrogels after immersion in a physiological 
solution (PBS, pH 7.4) at 37 ºC for 24 h. After that, the weight of the swollen hydrogels was 
measured and the results were expressed as percentage of swelling of the hydrogels according to 
the following equation (2): 
 SW% = ((Ws-Wd)/Wd)) ·100 (2) 
where Ws is the weight of the swollen hydrogel, Wd is the weight of the dry hydrogel and SW% 
is the percentage of water uptake. Five replicates of all samples were tested and the standard 
deviations were calculated. 
 12
 
In vitro studies of the inhibitory activity of the hydrogels over deleterious wound enzymes  
The inhibitory efficiency of the hydrogels against collagenase was estimated by measuring the 
increase in fluorescence intensity of fluorescently labeled gelatin (EnzChek substrate) cleaved in 
presence of collagenase. Briefly, 5 mg of hydrogel samples were incubated with 400 L 49 
U/mL collagenase, dissolved in EnzChek buffer for 24 h at 37 C. Thereafter 100 L of the 
incubated solution were transferred to 96-well microplate and mixed with 80 L buffer. After 
adding 20 L of 250 g/mL gelatin substrate solution, the measurement started at 
excitation/emission 493/528 nm. All measurements were performed in triplicate and the results 
were expressed as collagenase residual activity compared to the collagenase control solution 
without hydrogel.  
A quartz crystal microbalance (QCM) was used to monitor the Zn2+ binding capacity and 
collagenase adsorption on the gels. 5-MHz AT-cut quartz crystals, coated with optically flat 
polished Cr/Au electrodes were used in QCM200 from SRS Stanford Research Systems. Prior 
starting the experiments, the quartz crystals were immersed in 6M H2SO4 during 5 min, rinsed 
with ethanol and deionized water, and sonicated during 15 min. Thereafter, the crystals were 
gently rinsed with milliQ water and dried with nitrogen. The solutions were pumped at a flow 
rate of 80 µl min−1. At first, the hydrogel was placed on the top of the golden disk and the 
EnzChek kit buffer was circulated through the cell, until the steady state was reached. Then, this 
buffer was replaced with a new solution containing EnzChek kit buffer supplemented with 
Zn(NO3)2 or collagenase while monitoring the frequency. Once finished, this solution was 
replaced by the EnzChek kit buffer alone, reaching a new steady state. The difference between 
both steady states was correlated with the adsorption or binding capacity. 
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In order to measure the capacity of the hydrogels (3 mg samples) to entrap collagenase and 
thereby remove it from the wound bed, the hydrogels were incubated for up to seven days at 37 
C in presence of 500 µL 1 mg/mL collagenase solution. Bradford® kit was used to assess the 
amount of remaining enzyme protein in the solution. Immediately after incubation, 20 µL of 
each incubated solution were mixed with 280 µL Bradford reagent and the mixtures were 
incubated for 5 min, prior to monitoring the absorbance at 595 nm. The calibration curve was 
built after measuring the absorbance of serial dilutions of BSA in presence of equivalent amounts 
of Bradford reagent.  
The MPO inhibition by the hydrogels was measured using guaiacol as a substrate.32 To 
determine the impact of the amount of GA, samples (1 mg) prepared with the highest degree of 
chitosan thiolation and varying the concentration of GA (designated as 2.5TCS2-5, 5TCS2-5 and 
7.5TCS2-5) were incubated with 32 μL 0.25 U/mL MPO and 48 μL guaiacol (167 mM) solution 
buffered with 720 μL PBS pH 7.4 at 37 ºC. After 1 h incubation, 200 µL of the solution were 
placed in a 96-well microplate and the reaction was started by adding 22 µL of 1 mM H2O2. The 
change in the absorbance at 470 nm was monitored during 1 min using a microplate reader. All 
measurements were carried out in triplicate and the activity was determined by the rate of 
absorbance increase per min and expressed as a percentage of enzyme inhibition compared to the 
control (MPO reaction mixture without hydrogel sample). 
Ex vivo studies of inhibitory activity of the hydrogels over deleterious wound enzymes 
Wound exudates were extracted from the UrgoClean dressing (from Urgo Medical) of a 
patient with a venous leg ulcer (Hospital de Terrassa (Spain)). After removing the dressing from 
patient’s limb, 1 g specimen containing the exudate, was soaked in 5 mL Milli-Q water for 10 
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min. Thereafter, the mixture was vortexed for 3 min and centrifuged for 5 min at 10000 rpm. The 
extracted liquid was collected and centrifuged once again for 5 min at 10000 rpm to remove the 
sludge from the wound dressing, and finally stored in the fridge at 4 °C for further use. 
In order to investigate the MPO inhibition ability of the hydrogels, each hydrogel sample (1 
mg) was immersed in 720 μL phosphate buffer (0.1 M, pH 6.5), 48 μL guaiacol and 32 μL of the 
extracted wound fluid previously diluted 16 times in order to adjust the enzymatic assay 
conditions. After incubating the mixture for 1 h at 37 °C, the change in absorbance at 470 nm 
during a 3 min cycle was measured. The results were expressed as a percentage inhibition of 
MPO. Sample incubated in absence of hydrogel, served as a control and its MPO activity was 
taken as 100 % at the aforementioned conditions.  
For the evaluation of the inhibition efficiency of the hydrogels against MMPs, 400 μL of the 
chronic wound exudate, previously diluted 8 times with buffer (pH 7.4), was incubated for 24 h 
at 37 °C in presence of hydrogels with different degree of thiolation and the same concentration 
of GA. Then, the MMP inhibition by the hydrogels was measured as previously described. 
Sample incubated without hydrogel served as a control and the activity of MMPs in that sample 
was considered as 100 %. 
 
Radical scavenging activity 
The radical scavenging activity of the hydrogels was determined spectrophotometrically 
measuring the decrease of absorbance of the DPPH radical at 517 nm. Briefly, 2 mg of each 
hydrogel were incubated in 60 µM DPPH solution in methanol at 37 ºC in dark conditions for 30 
min. All measurements were performed in triplicate. The following equation (3) was used to 
calculate the antioxidant activity: 
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 DPPH inhibition (%) = [1 − (A/Ao)] × 100 (3) 
where Ao is the absorbance of the negative control (DPPH solution alone) and A is absorbance of 
DPPH, incubated with the hydrogels. 
Cytotoxicity studies 
Hydrogel samples (3 mg each) with different degree of thiolation and the highest concentration 
of GA (7.5 mM) were previously sterilized under UV-light for 1 hour. The samples were then 
placed in contact with 1 mL of complete growth medium (DMEM) in 24-well tissue culture-
treated polystyrene plate, containing 4.5 x 104 cells/well of human skin fibroblasts in a CO2 
incubator at 37 °C for one or seven days. Afterwards, the samples were removed and the growth 
media withdrawn. Media without hydrogel served as a negative control for 100 % cell viability. 
The previously seeded cells were put into contact with the withdrawn culture media and 
incubated at 37 °C in a humidified atmosphere of 5 % CO2 for 24 h. The cells were further 
examined for signs of toxicity using an AlamarBlue assay kit (AlamarBlue, Invitrogen). 
AlamarBlue was diluted in culture medium (10 % v/v) and added to each well after aspirating the 
culture medium containing the samples. The absorbance at 570 nm was measured with a 
microplate reader after 4 h incubation at 37 °C, setting 600 nm as a reference wavelength.  
Antibacterial activity 
S. aureus, E. coli and P. aeruginosa were grown on Baird-Parker, coliform and Cetrimide agar, 
at 37 ºC for 24 h. Suspensions of each strain were prepared at concentration of 106 CFU/ml. The 
hydrogel samples (3 mg each) were incubated with 500 µL of S. aureus, E. coli or P. aeruginosa 
suspensions for 24 h at 37 ºC and 450 rpm. Thereafter, different dilutions of the suspensions 
(prepared in sterile nutrient broth (NB)) were tested for bacterial growth on coliform, Baird-
Parker or Cetrimide agar for E. coli, S. aureus and P. aeruginosa, respectively, for 24 h. The 
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number of survived bacterial colonies was counted and the bacterial reduction ability of the 
hydrogels was calculated using the following equation (4): 
 Log reduction = log10 (B/C)  (4) 
where B and C are the average number of bacterial colonies at 24 h for bacteria incubated 
without (control sample) and with hydrogel, respectively. 
Data analysis  
Replicate samples were used in each measurement, and all values are presented as mean values 
± the standard deviations (SD). Results were analyzed using Graph Pad Prism version 7.0c 
(Graph Pad Software, San Diego, CA, USA). Statistical significances were determined using a 
one-way ANOVA followed by the Dunnett post-hoc test or by the unpaired two-tailed Student’s 
t-test method. P values ≤ 0.05 were considered statistically significant. 
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RESULTS AND DISCUSSION 
Enzyme-assisted hydrogel formation  
TCS/GA hydrogels were prepared via laccase-initiated crosslinking reaction. TCS/GA controls 
without laccase gelated after at least 8 h of incubation, suggesting that the gelation in absence of 
enzyme is governed by –SH oxidation by the atmospheric oxygen and –S-S- bonds formation.29 
Controls with non-thiolated chitosan, however, did not gelate even after 24 h of incubation. From 
these observations one may anticipate that in the formation of the hydrogel matrix both thiol and 
phenolic moieties were involved. The rationale of the gel formation (Scheme 1) lies in the 
laccase oxidation of phenols into reactive quinones33 that further participate in non-enzymatic 
autopolymerization reactions and crosslinking with nucleophilic groups (-SH and -NH2) from 
chitosan, leading to gel formation. Schiff-base formation (for -NH2) and 1-4 Michael-type 
addition (for -NH2 and -SH) are the possible reaction mechanisms between these nucleophiles 
and the aromatic ring of GA.34 Disulfide formation upon oxidation of the thiol groups in TCS 
may also contribute to further crosslinking of the gel as suggested by the gelation of the controls 
without laccase.  
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Scheme 1. Crosslinking reactions between TCS and GA leading to hydrogel formation. 
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To study the nature of the crosslinking reaction between GA and TCS, batches of 7.5 mM GA 
and TCS with different degree of thiolation were incubated with laccase for 2, 4 or 6 h. The 
percentage of residual thiol and phenolic groups in the obtained hydrogels was determined in 
order to elucidate the mechanism of the gelation process (Fig. 1). The similar results for 
7.5TCS1-10 and 7.5TCS1-5 samples in 2 h indicate that the crosslinking reaction has a similar 
initial rate, most probably due to the easy-available thiol groups in these specimens. However, 
increasing the incubation time, the phenolic groups from GA would react with the thiols groups 
in chitosan resulting in further crosslinking in the hydrogels containing higher amount of GA. In 
all cases, the content of free phenolic groups tends to decrease with the increase of the incubation 
time with laccase (Fig. 1A), supporting the oxidative transformation of the phenolic groups of 
GA into quinones. Moreover, the interdependence between the degree of thiolation of chitosan 
and the amount of residual phenolic groups indicates the participation of both groups in the 
crosslinking reaction. Hence, lowering the thiolation degree of chitosan, the coupling reaction 
and autopolymerization between the oxidized phenolic moieties is favored34 in addition to the 
possible physical interactions between chitosan and GA.35 Otherwise, in the sample with the 
highest degree of thiolation, the favored reaction is 1-4 Michael addition between the oxidized 
GA and the thiol groups, rather than the autopolymerization of the oxidized phenol groups. 
Another possible reaction mechanism between the oxidized GA and the nucleophilic –NH2 
groups could be the Schiff base formation.23  
In the same way, the amount of free thiol groups in each preparation (Fig. 1B) gradually 
decreased upon incubation with laccase, which can be explained with their involvement in 
crosslinking reaction with GA or formation of S-S bonds. The latter reaction, however, is 
strongly pH-dependent and is more likely to occur at alkaline pHs.36  
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After the first 2 h of incubation with laccase, nearly half of the free thiol groups were reacted 
independently on the TCS used. After 4 h, around 40 % of the initial amount of thiol groups 
remained, confirming the continuous crosslinking of the gel network. With the evolution of the 
hydrogel network structure, after 6 h of incubation with laccase, these changes became less 
noticeable. In the light of these results, further studies were conducted with TCS/GA hydrogels 
prepared after 2 h of incubation with the enzyme. In the following experiments, even after this 
prolonged enzymatic reaction time, the amount of residual free thiol and phenolic groups were 
found to be sufficient to confer to the hydrogels the necessary for chronic wound application 
bioactivity. 
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Figure 1. Percentage of residual A) phenolic and B) thiol groups in the hydrogels as a function 
of the incubation time with laccase. All results are reported as mean values ± SD (n=3) and their 
statistical significance was calculated using one-way ANOVA (p<0.05). 
 
The laccase-assisted TCS/GA hydrogel formation was followed in situ by rheological 
measurements (Fig. 2), which showed that the gelation point (cross-section of storage (G’) and 
loss (G’’) moduli) was reached at different time depending on the amount of thiol groups in 
TCS. Crosslinking evolution should result in increasing values of G´, and hence mechanically 
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stable hydrogel network, suitable for wound dressing application.8 The crosslinking of the TCS 
with the lowest degree of thiolation (7.5TCS1-10) begun with a parallel evolution of the storage 
and loss moduli, followed by a sudden rise and steeper increase of the storage modulus, which 
reached 3.8 Pa after 1200 s. For the same time the storage modulus of 7.5TCS1-5 reached a 
value of 30.2 Pa, and the sample 7.5TCS2-5 with the highest degree of thiolation ended at 260 
Pa. These results confirm that varying the thiolation degree of chitosan the mechanical properties 
of the resulting hydrogels can be tuned.  
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Figure 2. Rheological characterization of the enzymatically crosslinked hydrogels. Storage (G’) 
and loss (G’’) moduli vs. time at 50 ºC, laccase (2.7 U/ml), A) 7.5TCS1-10, B) 7.5TCS1-5, C) 
7.5TCS2-5. 
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Some release of polyphenols could be expected from the crosslinked TCS/GA hydrogels due 
to the presence of unreacted GA. Polyphenols release can be related to the inhibition of the 
deleterious chronic wound enzymes, in particular MPO,37 but may negatively affect the 
biocompatibility of the materials.38 Burst release of polyphenols was observed in all groups of 
hydrogels during the initial swelling of the material after 1 hour of incubation in PBS, followed 
by a slower diffusion over 24 hours (Fig. 3). Expectedly, the highest release of polyphenols was 
detected for the samples with the lowest degree of thiolation, while the hydrogels with the 
highest degree of thiolation, where more polyphenols are crosslinked with TCS, showed the 
lowest release of polyphenols, which is in accordance to the proposed crosslinking mechanism. 
Such cumulative GA release profile supports our concept for the design of a hydrogel dressing 
material for chronic wound application. The highest concentration of the active compounds in 
the wound providing elevated antioxidant activity and inhibitory effect on MPO and collagenase 
is required upon the application of the dressing on the wound, in order to initiate the healing 
process.55 The dressing material with enzymatically tunable degree of crosslinking, could be 
selected with higher or lower GA release depending on the wound complexity. After the initial 
burst release, corresponding to the non-covalently incorporated in the structure of the hydrogel 
phenolics, a minor sustained release was observed due to partial biodegradation of the hydrogel 
and diffusion of GA from the inner part of the matrix, maintaining the activity of the dressing for 
longer application periods. On the other hand, the covalently bound to the biomaterial GA, 
would exerts its bioactivity as long as the material is placed on the wound and is not degraded.  
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Figure 3. Release of polyphenols from hydrogels with different degree of thiolation over 24 h of 
incubation in PBS. All results are reported as mean values ± SD (n=3). 
 
 
 
FTIR analysis of the hydrogels 
The FTIR-spectra of the hydrogels are difficult for interpretation due to the large number of 
covalent and non-covalent interactions, resulting in overlapping and/or low intensity of the 
peaks. Nevertheless, clear differences were observed for all samples after the enzymatic 
crosslinking reaction. The increase of the intensity of the peak at 1407 cm-1 in the spectrum39 of 
7.5TCS2-5 (Fig. 4) compared to the TCS2-5 control can be assigned to CH-vibration in the -
CH2S- group resulting from Michael addition reactions between the oxidized GA and the 
nucleophilic -SH groups of TCS. On the other hand, the characteristic shoulder of -SH stretching 
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band around 2550 cm-1 significantly decreased in the hydrogel spectrum, confirming the 
involvement of these groups in different interactions.  
In order to elucidate the mechanism of crosslinking, we analyzed the FTIR-spectra of L-
cysteine (as a rough approximation of a molecule with both –NH2 and –SH groups) 
enzymatically reacted with GA (inset Fig. 4). Similar to 7.5TCS2-5 decrease of the peak 
characteristic for –SH groups at 2550 cm-1(Fig. SI.1), confirmed their involvement in Michael 
addition reaction. The appearance of new weak signals at 2980 cm-1 and 1306 cm-1, can be 
attributed to CH2-stretching (symmetric and asymmetric) and CH2-wagging vibrations, 
respectively. These peaks most probably appeared as a result of -CH2S- formation. The newly 
appeared band at 1125 cm-1 is due to the stretching vibration of the aromatic ring of GA of the -
S-Ar bond. The bands at 776, 846 and 963 cm-1 can be assigned to different skeletal vibrations 
caused by the addition of cysteine to the GA aromatic ring. These findings corroborate the initial 
hypothesis for Michael addition reaction between TCS and GA in the laccase-initiated 
crosslinking reaction. 
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Figure 4. FTIR-spectra of hydrogel sample 7.5TCS2-5 and TCS2-5 control. The inset 
corresponds to L-cysteine/GA laccase-crosslinked material and its control without laccase in the 
range of 1300-650 cm-1. 
 
Morphology of the hydrogels  
The cross-sectional SEM images (Fig. 5) of representative freeze-dried hydrogels revealed 
porous structures with pore size and shape depending on the amount of GA used. SEM images of 
the enzymatically crosslinked hydrogels containing the lowest concentration (2.5 mM) of GA 
produced porous structure with pores with an average diameter of 135μm. Increasing the 
concentration of GA resulted in decrease of the pore size, where the hydrogel 5TCS2-5 reached 
105 μm and the sample with the highest concentration (7.5 mM) of GA showed the densest 
network with the smallest (29 μm average diameter) pore size. These gel morphologies are in 
line with the suggested mechanism for hydrogel formation due to crosslinking reactions between 
the –SH and –NH2 nucleophiles from TCS and the aromatic ring of GA. 
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Figure 5. SEM images of lyophilized hydrogels prepared with TCS2-5 and different 
concentrations of GA: A) 2.5TCS2-5, B) 5TCS2-5, and C) 7.5TCS2-5, after 2 h of incubation 
with laccase.  
The pore size of a hydrogel is a physical characteristic related with the swelling capacity of 
the hydrogels, i.e. greater degree of crosslinking results in smaller size of the pores and hence 
less swelling capacity. The crosslinking degree of the hydrogel is also directly related to its 
stability in vivo and susceptibility to degradation by wound enzymes. In addition, the pore size 
might have impact on drug release profiles since smaller pore sizes will have more sustained and 
prolonged release. In our hydrogels, GA is the active principle and is incorporated covalently in 
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the structure of the hydrogel, while the non-covalently reacted GA was burst released at contact 
of the hydrogel with liquid media. 
 
Swelling ratio of the hydrogels  
To promote healing of chronic wounds, the dressing should maintain a moist wound 
environment while absorbing the excessive e xudates.40,41 The amount of liquid absorbed by the 
hydrogel is usually a function of the degree of its crosslinking. Accordingly, the impact of 
factors responsible for hydrogel crosslinking, e.g. the incubation time with laccase and the 
concentration of GA, on the swelling capacity was evaluated (Fig. 6). Increasing the duration of 
the enzymatic reaction resulted in the decrease of the hydrogel swelling ratio due to the 
crosslinking evolution, as supported by the decrease of both phenolic and thiol groups in the 
material (Fig. 1). The primary function of a hydrogel is to absorb liquids, remaining 
mechanically stable. Therefore, the combined rheological, morphological and swelling ratio data, 
together with the amount of residual phenolic and thiol groups indicated that the optimum in 
terms of structural and functional features hydrogel was achieved upon 2 h of incubation with 
laccase of the formulation with the highest phenol and thiol content (7.5TCS2-5).  
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Figure 6. Swelling capacity of the hydrogels prepared with TCS2-5 and varying the 
concentration of GA after 2, 4 and 6 h of incubation with laccase. All results are reported as 
mean values ± SD (n=5) and statistical significance was calculated using one-way ANOVA 
comparing different incubation times (p<0.05). 
 
Stability of the hydrogels 
One of the required exploitation properties of chronic wound dressings is their biostability 
during the prolonged, up to six days, application.20 Thus, we studied the susceptibility of our best 
hydrogel candidate (7.5TCS2-5) to biodegradation upon elevated lysozyme activity.42 After six 
days of incubation in physiological solution (PBS) with lysozyme, 66 % of the initial weight of 
the gel was preserved (Fig. 7). The enzymatic digestion of the hydrogel did not show significant 
differences (p<0.05) when compared to the gel degradation in PBS without lysozyme. The 
structural stability of the hydrogel could be maintained due to the covalent crosslinking of the gel 
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matrix, limiting the access of lysozyme to the susceptible to hydrolysis β-(1–4) glycoside 
linkages between the monosaccharide residues. 
 
Figure 7. Stability of 7.5TCS2-5 in PBS alone and in presence of lysozyme. All results are 
reported as mean values ± SD (n=5). and their statistical significance was calculated using two-
tailed Student´s t-test method (p<0.05).  
 
 
Zn2+ binding capacity 
Zn2+ ions are cofactors for the activity of bacterial collagenases and MMPs.43,5 Thus, 
sequestering Zn2+ from the active center of these enzymes by the sulfhydryl groups in TCS 
would result in their inhibition. Herein, the QCM measurements showed that the hydrogels with 
the highest degree of thiolation (TCS2-5) present larger Zn2+ binding capacity as the GA content 
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is enlarged. Therefore, Zn2+ might be chelated by both the thiol groups of the thiolated chitosan 
and the crosslinked polyphenols that are capable of complexing different metal ions to a metal-
phenolic network.44  
Radical scavenging activity 
Immune cells produce ROS, which in low concentrations provide defense against 
microorganisms. In chronic wounds, however, the predominant hypoxic and inflammatory 
environment increases ROS production, which leads to stimulation of proteases and 
inflammatory cytokines, damages ECM proteins and causes cell death.45 The application of 
strong antioxidants reducing ROS to normal levels, was reported to reverse the chronicity and 
improve wound healing in an animal model.45 The GA used in our study is largely explored for 
its antioxidant activity.46 Additionally, the antioxidant and radical scavenging capacities of thiols 
have been also demonstrated.47 Consequently, the DPPH assay revealed radical scavenging 
activity of all tested hydrogels as a function of the increasing concentration of GA used for their 
preparation (Fig. 8). The high radical scavenging activity observed might be related to the 
released polyphenols from the hydrogel matrix. 5TCS2-5 and 7.5TCS2-5 inhibit DPPH nearly 
100 % most probably due to the media saturation with sufficient amount of polyphenols. 
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Figure 8. DPPH radical scavenging activity of hydrogels prepared with TCS2-5, different 
concentrations of GA and incubated for 2 h with laccase for gelation. The error bars indicate the 
standard deviation of three independent experiments and the statistical significance was 
calculated using one-way ANOVA (p<0.05).  
 
Antibacterial activity of the hydrogels 
The antibacterial activity of the hydrogels was assessed against three clinically relevant 
bacterial strains - the Gram-positive S. aureus and the Gram-negative E. coli and P. 
aeruginosa48,49 during 24 h of incubation. The hydrogels inhibited E. coli, S. aureus and P. 
aeruginosa up to 1.7, 2.2 and 3.1 log, respectively (Fig. 9 and SI.3). As reported, chitosans with 
low Mw show negligible antibacterial activity.50 However, a study from our group demonstrated 
that the modification of low Mw chitosan (15 kDa) with 2-iminothiolane hydrochloride improved 
its antibacterial properties.51 Thiolation with Traut’s reagent increases the cationic character of 
chitosan, enhancing its bacterial membrane disturbing capacity.17 The porous structure of the 
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hydrogel may also contribute to the retention and eradication of bacteria through a ‘trap and kill’ 
mechanism.52  
 
 
Figure 9. Antibacterial activity of the hydrogels against S. aureus and E. coli. The hydrogels 
were prepared with TCS2-5 and different concentrations of GA, and incubated 2 h with laccase 
for gelation. All results are reported as mean values ± SD (n=3) and their statistical significance 
was calculated using one-way ANOVA (p<0.05). 
The increase of the amount of GA in the hydrogel preparation would have a dual positive effect 
on the hydrogel structure and performance. On the one hand, increasing the amount of GA would 
provide increased crosslinking of the hydrogel, better stability, and smaller pore size, thus acting 
as a structural element. On the other hand, GA provides antimicrobial effect to the hydrogels 46 
Two distinct tendencies were observed for the antimicrobial efficiency of the hydrogels against 
gram-positive or negative strains, also outlined in a previous work of our group.53 The groups 
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providing the antimicrobial efficiency of chitosan and thiolated chitosan are respectively -NH3+ 
54 and =NH2+ 51 that react with the predominantly negative charges on the surface of the bacterial 
cells. These groups, however, are less accessible in the structure of the crosslinked hydrogels 
participating also in the crosslinking reactions during hydrogel formation.8 In Gram-positive 
bacteria, e.g. S. aureus, the interactions of the phenolic groups of GA with the lipid head groups 
of the lipid membrane, may disturb its integrity and subsequently lead to leakage of cellular 
components.55 The minimum bacterial reduction was similar for all tested hydrogels, whereas the 
maximum of bacterial reduction was almost doubled for the hydrogel with the higher initial 
phenol content.  
In Gram-negative bacteria, such as E. coli (Fig.9) and P. aeruginosa (Fig. SI.3), the 
antibacterial effect of the hydrogel is most probably due to the available –NH2 in chitosan, which 
amount progressively decreases increasing the amount of GA and the possible 1,4-Michael 
addition or Schiff base crosslinking reactions. Consequently, the antimicrobial effects in the case 
of Gram-negative bacteria decreased with the increase of phenol content. 
 
Cytotoxicity of the hydrogels 
Fibroblasts in the dermis have the functions of: 1) ECM synthesizing cells, and 2) signaling 
cells by secreting growth factors important for the intercellular signaling and skin repair. 
However, fibroblasts isolated from chronic wounds have negligible replicative ability.56 Thus, 
the biocompatibility of the hydrogel matrices is a crucial characteristic for their application as 
chronic wounds dressings. The results from cytotoxicity measurements with human foreskin 
fibroblast cells showed that the samples 7.5TCS1-10 and 7.5TCS1-5 were slightly cytotoxic, 
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while our best dressing candidate (7.5TCS2-5) showed above 90 % cells survival (Fig. 10), 
explained by the low release of polyphenols from this hydrogel (Fig. 3). 
 
Figure 10. Viability of human skin fibroblasts after one and seven days incubation at 37 ºC with 
hydrogels with different degree of thiolation. All results are reported as mean values ± SD (n=3) 
and their statistical significance was calculated using one-way ANOVA (p<0.05).   
 
In vitro and ex vivo inhibition of chronic wound enzymes 
MPO inhibition  
MPO originates from polymorphonuclear neutrophils, which are the first cell type activated by 
the host immune defense against infection in humans.57 The primary physiological function of 
MPO is to neutralize invading microorganisms generating hypochlorous acid (HClO).58 MPO 
can follow two different catalytic cycles, depending on the substrate availability - halogenation 
or peroxidase cycle. Recently, our group demonstrated that the polyphenols can act either as 
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HClO scavenger or can be directly involved in the peroxidase cycle as substrates, thereby 
inhibiting the chlorination activity of the enzyme.59 On the other hand, thiol groups have been 
also reported to inhibit MPO.60  
The MPO inhibition by hydrogels prepared with different concentrations of GA and the 
highest degree of chitosan thiolation (TCS2-5) was evaluated in vitro and ex vivo with venous 
leg ulcer exudates (Fig 11 A). Varying the concentration of GA in the hydrogels with the highest 
degree of thiolation (TCS2-5) resulted in up to 95 % MPO inhibition in vitro depending on the 
phenolic content. Despite of the complex composition of the clinically isolated exudates, the 
hydrogels were able to inhibit between 60 and 90 % of MPO in the ex vivo experiments. Most 
probably, this strong MPO inhibition was due to the burst release of phenolics during the first 
hour of incubation. Other contributions include the adsorption of MPO onto the hydrogel matrix 
and subsequent inhibition by the immobilized thiol60 and phenolic groups. 
Collagenase inhibition 
The capacity of the hydrogels to inhibit collagenase was studied in terms of amount of enzyme 
protein removed from the wound bed and retained in the hydrogel and anti-protease activity in 
vitro and ex vivo. After incubation with the hydrogels, up to 23 % of the enzyme protein was 
retained in their structure as a function of the GA content (Fig. SI.4) This effect is correlated 
with the affinity of proteins to form non-covalent complexes with polyphenols and to covalently 
interact with quinones.61,62 Therefore, the presence of polyphenols may contribute to the 
adsorption of enzyme protein, while the –SH groups could inactivate collagenase chelating the 
Zn2+ from its active center. 
Clinically demonstrated inhibition by adsorption of the positively charged MMPs was 
achieved by the PROMOGRAN™ dressing containing negatively charged oxidized regenerated 
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cellulose.63 In our study, the increased positive charge of chitosan after thiolation with Traut’s 
reagent should repel the positively charged MMPs, whereas the negative charge of the carboxylic 
moiety in GA could contribute for their electrostatic binding. 
The presence of MMPs in chronic wound exudates is the main factor for the excessive 
degradation of ECM. Their suppression is considered as an important factor in wound repair.64,65 
Thus, we studied the collagenase inhibition by the hydrogels in vitro and ex vivo (Fig. 11 B). The 
most significant collagenase inhibition (23 % in vitro and 68 % ex vivo) was achieved by the 
hydrogel with the highest phenol and thiol content (7.5TCS2-5). These results are consistent with 
the data for the Zn2+ binding capacity of the hydrogels, where 7.5TCS2-5 presented the highest 
Zn2+ binding capacity. Remarkably, a clear dependence of MMP inhibition on the GA content of 
the hydrogels can be extracted from the ex vivo studies. 
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Figure 11. In vitro and ex vivo inhibitory efficiency of the hydrogels against A) MPO and B) 
MMPs. The ex vivo experiments were performed by using a clinical isolate, extracted from a 
patient with venous leg ulcer. The hydrogels were prepared from TCS2-5 and increasing 
concentrations of GA, incubated 2 h with laccase for gelation. All results are reported as mean 
values ± SD (n=3) and their statistical significance was calculated using one-way ANOVA 
(p<0.05). 
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CONCLUSIONS  
 
The increasing incidence of chronic wounds calls for the development of bioactive dressing 
materials to address the complex oxidative and proteolytic environment of these wounds and 
promote their healing. Herein, we enzymatically synthesized novel biocompatible and stable in 
physiological conditions multifunctional hydrogels, which efficiently inhibited oxidative and 
proteolytic enzymes in vitro, scavenged ROS and eradicated clinically relevant E. coli, P. 
aeruginosa and S. aureus. The laccase-assisted crosslinking of GA and TCS via quinone/thiol 
coupling reactions allowed for building of hydrogel networks with tunable mechanical and 
functional properties. The hydrogels inhibited the MPO and collagenase activities by 90 and 68 
%, respectively in ex vivo experiments with diabetic leg ulcer exudates. These novel biopolymer 
dressing materials illustrate an integrated strategy for chronic wound management, upgrading the 
widely accepted concept for maintaining the moisture environment of the wound with 
bioactivities to control major factors governing wound chronicity.  
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